Cargando…
Microarrays and breast cancer clinical studies: forgetting what we have not yet learnt
This review takes a sceptical view of the impact of breast cancer studies that have used microarrays to identify predictors of clinical outcome. In addition to discussing general pitfalls of microarray experiments, we also critically review the key breast cancer studies to highlight methodological p...
Autores principales: | Ahmed, Ahmed Ashour, Brenton, James D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1143564/ https://www.ncbi.nlm.nih.gov/pubmed/15987437 http://dx.doi.org/10.1186/bcr1017 |
Ejemplares similares
-
Parliaments lead the change for women’s, children’s and adolescents’ health: what have we learnt?
por: Toure, Kadidiatou, et al.
Publicado: (2021) -
Proximal tubular dysfunction in patients with COVID-19: what have we learnt so far?
por: Braun, Fabian, et al.
Publicado: (2020) -
Swine flu-have we learnt any lesson from the past?
por: Yadav, Sankalp, et al.
Publicado: (2015) -
Defining transposition: What have we learnt?
por: Roderick, Max E., et al.
Publicado: (2021) -
What have we learnt from Covid?
por: Salter, Mark Steven
Publicado: (2021)